Business Context and Reporting Period
This Form 8-K filing by Henry Schein, Inc. (HSIC) covers events occurring on May 24 and May 25, 2005. Henry Schein is the largest distributor of healthcare products and services in North America and Europe, operating through four business groups: Dental, Medical, International, and Technology. The company serves over 475,000 customers in more than 125 countries and reported record sales of $4.1 billion in 2004.
Key Financial Metrics and Liquidity
- New Credit Facility: $300 million revolving credit facility with a $100 million expansion feature.
- Facility Maturity: May 2010.
- Historical Performance: Average annual compound EBITDA growth exceeding 16% over the last five years.
- 2004 Revenue: $4.1 billion (record sales).
- Net Income, Cash Flow, and Debt Levels: The filing text does not provide specific values for current net income, operating cash flow, or total debt outstanding.
Material Changes Versus Prior Period
The primary material change is the replacement of the company's existing revolving credit facility, which was scheduled to mature in May 2006, with a new facility extending the maturity date to May 2010. This transaction extends the company's borrowing horizon by four years and increases the available credit capacity through the addition of a $100 million expansion feature.
Guidance, Outlook, and Management Commentary
Management, specifically Executive Vice President and Chief Financial Officer Steven Paladino, characterized the transaction as an "attractive long-term borrowing facility" that reflects the company's strong credit profile. The funds are designated for general corporate purposes, including working capital, capital expenditures, and potential acquisitions. The company anticipates utilizing the syndicate's commercial banking structure to support its growing worldwide needs. No specific financial guidance or risk factors regarding future performance were detailed in this specific filing.
Important Facts for Investor Verification
- Verify the specific interest rate margins and fees associated with the new $300 million facility.
- Confirm the current utilization rate of the new credit facility and total outstanding debt.
- Review the specific covenants and financial maintenance requirements attached to the new agreement.
- Assess the company's current liquidity position relative to the new borrowing capacity.